Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis.
Becherini C, Visani L, Caini S, Bhattacharya IS, Kirby AM, Nader Marta G, Morgan G, Salvestrini V, Coles CE, Cortes J, Curigliano G, de Azambuja E, Harbeck N, Isacke CM, Kaidar-Person O, Marangoni E, Offersen B, Rugo HS, Morandi A, Lambertini M, Poortmans P, Livi L, Meattini I. Becherini C, et al. Among authors: visani l. Cancer Treat Rev. 2023 Sep;119:102586. doi: 10.1016/j.ctrv.2023.102586. Epub 2023 Jun 15. Cancer Treat Rev. 2023. PMID: 37336117 Free article. Review.
Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma.
Pasqualetti F, Montemurro N, Desideri I, Loi M, Giannini N, Gadducci G, Malfatti G, Cantarella M, Gonnelli A, Montrone S, Visani L, Scatena C, Naccarato AG, Perrini P, Gambacciani C, Santonocito O, Morganti R, Paiar F. Pasqualetti F, et al. Among authors: visani l. Acta Neurol Belg. 2022 Apr;122(2):441-446. doi: 10.1007/s13760-021-01765-4. Epub 2021 Aug 16. Acta Neurol Belg. 2022. PMID: 34396487
Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions.
Scoccianti S, Francolini G, Carta GA, Greto D, Detti B, Simontacchi G, Visani L, Baki M, Poggesi L, Bonomo P, Mangoni M, Desideri I, Pallotta S, Livi L. Scoccianti S, et al. Among authors: visani l. Crit Rev Oncol Hematol. 2018 Jun;126:80-91. doi: 10.1016/j.critrevonc.2018.03.024. Epub 2018 Mar 31. Crit Rev Oncol Hematol. 2018. PMID: 29759570 Review.
Influence of age and subtype in outcome of operable liposarcoma.
Greto D, Saieva C, Loi M, Terziani F, Visani L, Garlatti P, Lo Russo M, Muntoni C, Becherini C, Topulli J, Campanacci D, Beltrami G, Scoccianti G, Muratori F, Bonomo P, Desideri I, Francolini G, Livi L. Greto D, et al. Among authors: visani l. Radiol Med. 2019 Apr;124(4):290-300. doi: 10.1007/s11547-018-0958-4. Epub 2018 Nov 12. Radiol Med. 2019. PMID: 30421387
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer.
Desideri I, Francolini G, Scotti V, Pezzulla D, Becherini C, Terziani F, Delli Paoli C, Olmetto E, Visani L, Meattini I, Greto D, Bonomo P, Loi M, Detti B, Livi L. Desideri I, et al. Among authors: visani l. Clin Transl Oncol. 2019 Jul;21(7):933-938. doi: 10.1007/s12094-018-02005-7. Epub 2018 Dec 18. Clin Transl Oncol. 2019. PMID: 30565084
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial.
Livi L, Scotti V, Desideri I, Saieva C, Cecchini S, Francolini G, Becherini C, Delli Paoli C, Visani L, Salvestrini V, De Feo ML, Nori J, Bernini M, Sanchez L, Orzalesi L, Bianchi S, Meattini I. Livi L, et al. Among authors: visani l. Eur J Cancer. 2019 Feb;108:100-110. doi: 10.1016/j.ejca.2018.12.005. Epub 2019 Jan 14. Eur J Cancer. 2019. PMID: 30648627 Clinical Trial.
Efficacy and Tolerability of CyberKnife Stereotactic Robotic Radiotherapy for Primary or Secondary Orbital Lesions: A Single-Center Retrospective Experience.
Desideri I, Francolini G, Carta GA, Di Cataldo V, Masi L, Meattini I, Bonomo P, Loi M, Greto D, Visani L, Lo Russo M, Grassi R, Teriaca MA, Garlatti P, Nardi C, Livi L. Desideri I, et al. Among authors: visani l. Technol Cancer Res Treat. 2019 Jan 1;18:1533033818818561. doi: 10.1177/1533033818818561. Technol Cancer Res Treat. 2019. PMID: 30803353 Free PMC article. Clinical Trial.
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal?
Bonomo P, Greto D, Desideri I, Loi M, Di Cataldo V, Orlandi E, Iacovelli NA, Becherini C, Visani L, Salvestrini V, Mariotti M, Livi L. Bonomo P, et al. Among authors: visani l. Oral Oncol. 2019 Jun;93:1-7. doi: 10.1016/j.oraloncology.2019.04.006. Epub 2019 Apr 8. Oral Oncol. 2019. PMID: 31109688
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma.
Greto D, Saieva C, Loi M, Desideri I, Delli Paoli C, Lo Russo M, Pezzulla D, Teriaca MA, Lucidi S, Visani L, Terziani F, Olmetto E, Becherini C, Bonomo P, Francolini G, Campanacci DA, Scoccianti G, Livi L. Greto D, et al. Among authors: visani l. Am J Clin Oncol. 2019 Oct;42(10):749-754. doi: 10.1097/COC.0000000000000594. Am J Clin Oncol. 2019. PMID: 31503061
64 results